Human Metastatic Melanoma Cell Lines Panel for In Vitro and In Vivo Investigations
The melanoma origin of cell lines obtained from the axillary lymph node (mel Kas, mel Pet, and mel Lap from patients with a verified diagnosis) was confirmed by the detection of the Melan A melanocyte marker expression. A hyperdiploid (2n+) for the mel Kas line; near-diploid (2n), and in some cells...
Saved in:
Main Authors: | Ekaterina N. Kosobokova (Author), Nadezhda A. Kalinina (Author), Ksenia M. Konoplina (Author), Anastasiia A. Malchenkova (Author), Alexandra E. Evdokimova (Author), Marina V. Piniugina (Author), Irina I. Khan (Author), Ilya A. Kislyak (Author), Anna A. Basharina (Author), Anna N. Grishanina (Author), Anna A. Rudakova (Author), Pavel O. Varaksa (Author), Maria A. Baryshnikova (Author), Vadim S. Pokrovsky (Author), Tatiana A. Bogush (Author), Vyacheslav S. Kosorukov (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chlorin e6 Phospholipid Delivery System Featuring APN/CD13 Targeting Peptides: Cell Death Pathways, Cell Localization, In Vivo Biodistribution
by: Yulia A. Tereshkina, et al.
Published: (2022) -
Efficacy of the Recombinant Tuberculosis Allergen for Early Identification of Latent Tuberculosis in Children and Adolescents in General Healthcare Settings
by: V. A. Aksenova, et al.
Published: (2015) -
REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS
by: M. N. Mamedov, et al.
Published: (2015) -
REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS
by: M. N. Mamedov, et al.
Published: (2015) -
New approaches on diabetes mellitus management
by: Ilya A. Barsukov, et al.
Published: (2023)